 Christopher Baker
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 22 | 2023 | 333 | 5.820 |
Why?
| | Tracheostomy | 14 | 2023 | 97 | 5.030 |
Why?
| | Respiration, Artificial | 15 | 2023 | 536 | 3.730 |
Why?
| | Infant, Premature | 16 | 2023 | 479 | 1.830 |
Why?
| | Respiratory Insufficiency | 4 | 2021 | 285 | 1.580 |
Why?
| | Ventilator Weaning | 3 | 2016 | 33 | 1.540 |
Why?
| | Home Care Services | 4 | 2022 | 219 | 1.340 |
Why?
| | Ventilators, Mechanical | 7 | 2023 | 51 | 1.180 |
Why?
| | Infant, Newborn | 26 | 2023 | 5032 | 1.160 |
Why?
| | Infant, Premature, Diseases | 2 | 2021 | 88 | 1.080 |
Why?
| | Continuity of Patient Care | 3 | 2017 | 252 | 1.040 |
Why?
| | Fetal Blood | 5 | 2016 | 266 | 1.010 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 12 | 0.960 |
Why?
| | Patient Care Team | 4 | 2022 | 518 | 0.930 |
Why?
| | Infant | 19 | 2023 | 7922 | 0.880 |
Why?
| | Respiratory Tract Diseases | 2 | 2022 | 139 | 0.870 |
Why?
| | Stem Cells | 3 | 2013 | 538 | 0.850 |
Why?
| | Premature Birth | 4 | 2023 | 274 | 0.830 |
Why?
| | Tracheomalacia | 1 | 2022 | 18 | 0.790 |
Why?
| | Tracheoesophageal Fistula | 1 | 2022 | 30 | 0.780 |
Why?
| | Infant, Extremely Premature | 4 | 2022 | 57 | 0.780 |
Why?
| | Trachea | 1 | 2023 | 220 | 0.750 |
Why?
| | Child | 26 | 2023 | 18340 | 0.750 |
Why?
| | Device Removal | 3 | 2019 | 122 | 0.750 |
Why?
| | Airway Extubation | 2 | 2019 | 43 | 0.750 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 102 | 0.730 |
Why?
| | Deglutition Disorders | 1 | 2022 | 117 | 0.720 |
Why?
| | Lung | 6 | 2023 | 3497 | 0.670 |
Why?
| | Patient Discharge | 5 | 2022 | 770 | 0.670 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.650 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 13 | 0.650 |
Why?
| | Tracheal Diseases | 1 | 2019 | 13 | 0.650 |
Why?
| | Endothelial Cells | 4 | 2013 | 677 | 0.650 |
Why?
| | Humans | 53 | 2023 | 113531 | 0.610 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 102 | 0.610 |
Why?
| | Curriculum | 3 | 2021 | 803 | 0.590 |
Why?
| | Hypertension, Pulmonary | 5 | 2018 | 1733 | 0.560 |
Why?
| | Animals, Newborn | 3 | 2015 | 769 | 0.550 |
Why?
| | Pulmonary Alveoli | 3 | 2018 | 369 | 0.550 |
Why?
| | Pamphlets | 1 | 2016 | 22 | 0.540 |
Why?
| | Endothelial Progenitor Cells | 1 | 2016 | 17 | 0.540 |
Why?
| | Simulation Training | 1 | 2017 | 62 | 0.530 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2016 | 60 | 0.520 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 105 | 0.510 |
Why?
| | Airway Obstruction | 2 | 2021 | 158 | 0.510 |
Why?
| | Lung Diseases | 1 | 2021 | 688 | 0.490 |
Why?
| | Hyperoxia | 3 | 2013 | 97 | 0.470 |
Why?
| | Clinical Protocols | 1 | 2016 | 231 | 0.470 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 174 | 0.470 |
Why?
| | Pre-Eclampsia | 1 | 2016 | 165 | 0.470 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2022 | 87 | 0.460 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1465 | 0.450 |
Why?
| | Self Care | 1 | 2016 | 350 | 0.450 |
Why?
| | Central Nervous System Diseases | 1 | 2014 | 60 | 0.450 |
Why?
| | Organogenesis | 1 | 2014 | 55 | 0.440 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 280 | 0.430 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 103 | 0.420 |
Why?
| | Quality Improvement | 2 | 2017 | 951 | 0.420 |
Why?
| | Regeneration | 1 | 2014 | 158 | 0.410 |
Why?
| | Bronchitis, Chronic | 1 | 2012 | 17 | 0.410 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 37 | 0.410 |
Why?
| | Umbilical Cord | 1 | 2013 | 80 | 0.400 |
Why?
| | Patient Education as Topic | 1 | 2016 | 665 | 0.400 |
Why?
| | Caregivers | 2 | 2017 | 713 | 0.380 |
Why?
| | Developmental Disabilities | 1 | 2014 | 235 | 0.380 |
Why?
| | Bleomycin | 1 | 2013 | 227 | 0.380 |
Why?
| | Interleukin-8 | 1 | 2012 | 230 | 0.380 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 345 | 0.380 |
Why?
| | Child, Preschool | 9 | 2023 | 9093 | 0.380 |
Why?
| | Length of Stay | 1 | 2016 | 963 | 0.370 |
Why?
| | Communication | 1 | 2016 | 734 | 0.360 |
Why?
| | Sputum | 1 | 2012 | 284 | 0.350 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2013 | 185 | 0.350 |
Why?
| | Hospital Mortality | 1 | 2014 | 780 | 0.350 |
Why?
| | Acute Lung Injury | 1 | 2013 | 266 | 0.330 |
Why?
| | Positive-Pressure Respiration | 3 | 2023 | 67 | 0.330 |
Why?
| | Algorithms | 1 | 2016 | 1462 | 0.320 |
Why?
| | Postoperative Complications | 1 | 2019 | 2120 | 0.310 |
Why?
| | Female | 18 | 2023 | 59115 | 0.300 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.300 |
Why?
| | Neutrophils | 1 | 2012 | 1072 | 0.290 |
Why?
| | Skin Pigmentation | 1 | 2007 | 39 | 0.290 |
Why?
| | Silver | 1 | 2007 | 27 | 0.290 |
Why?
| | Morbidity | 3 | 2022 | 275 | 0.260 |
Why?
| | Chronic Disease | 3 | 2021 | 1570 | 0.260 |
Why?
| | Male | 14 | 2019 | 55112 | 0.240 |
Why?
| | Pregnancy | 5 | 2021 | 5490 | 0.240 |
Why?
| | Cells, Cultured | 4 | 2016 | 3802 | 0.220 |
Why?
| | von Willebrand Diseases | 1 | 2022 | 11 | 0.200 |
Why?
| | von Willebrand Factor | 1 | 2022 | 55 | 0.200 |
Why?
| | Ambulatory Care | 2 | 2022 | 480 | 0.190 |
Why?
| | Insufflation | 1 | 2021 | 9 | 0.190 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 14 | 0.190 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 66 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2016 | 1065 | 0.180 |
Why?
| | Retrospective Studies | 6 | 2023 | 12504 | 0.180 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 175 | 0.180 |
Why?
| | Steroids | 2 | 2022 | 138 | 0.170 |
Why?
| | Aftercare | 1 | 2021 | 187 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 2 | 2013 | 487 | 0.170 |
Why?
| | Emergencies | 1 | 2020 | 144 | 0.170 |
Why?
| | Tracheotomy | 1 | 2019 | 21 | 0.160 |
Why?
| | Polysomnography | 1 | 2019 | 135 | 0.160 |
Why?
| | Adolescent | 4 | 2022 | 17724 | 0.150 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 953 | 0.150 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.150 |
Why?
| | Young Adult | 3 | 2019 | 10400 | 0.150 |
Why?
| | Dental Cements | 1 | 2017 | 20 | 0.150 |
Why?
| | Pediatrics | 3 | 2021 | 981 | 0.140 |
Why?
| | Cell Proliferation | 3 | 2013 | 2164 | 0.140 |
Why?
| | Transitional Care | 1 | 2017 | 35 | 0.140 |
Why?
| | Long-Term Care | 1 | 2017 | 77 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 2752 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2015 | 125 | 0.140 |
Why?
| | Infant Care | 1 | 2016 | 42 | 0.130 |
Why?
| | Computer Simulation | 1 | 2020 | 858 | 0.130 |
Why?
| | Expectorants | 1 | 2016 | 24 | 0.130 |
Why?
| | Rats | 2 | 2015 | 4829 | 0.130 |
Why?
| | Interrupted Time Series Analysis | 1 | 2016 | 46 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2022 | 801 | 0.130 |
Why?
| | Tidal Volume | 1 | 2016 | 73 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 480 | 0.130 |
Why?
| | Pulmonary Medicine | 1 | 2016 | 69 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 488 | 0.120 |
Why?
| | Echocardiography | 1 | 2017 | 563 | 0.120 |
Why?
| | Diuretics | 1 | 2015 | 64 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2016 | 205 | 0.120 |
Why?
| | Risk Factors | 3 | 2019 | 8606 | 0.120 |
Why?
| | Adrenergic beta-Agonists | 1 | 2015 | 125 | 0.110 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 247 | 0.110 |
Why?
| | United States | 5 | 2022 | 12137 | 0.110 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 494 | 0.110 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 68 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 191 | 0.100 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2013 | 109 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 291 | 0.100 |
Why?
| | Survival Rate | 1 | 2016 | 1634 | 0.100 |
Why?
| | Colorado | 2 | 2019 | 4061 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2015 | 231 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 920 | 0.090 |
Why?
| | Time Factors | 2 | 2019 | 6032 | 0.090 |
Why?
| | Survival Analysis | 1 | 2014 | 1203 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2016 | 9006 | 0.090 |
Why?
| | Maternal Exposure | 1 | 2012 | 138 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1128 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 902 | 0.080 |
Why?
| | Risk | 1 | 2012 | 807 | 0.080 |
Why?
| | Outpatients | 2 | 2023 | 324 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4384 | 0.080 |
Why?
| | Animals | 3 | 2015 | 31162 | 0.080 |
Why?
| | Risk Assessment | 1 | 2017 | 2953 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2139 | 0.080 |
Why?
| | Biomarkers | 1 | 2017 | 3389 | 0.070 |
Why?
| | Colloids | 1 | 2007 | 56 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1012 | 0.070 |
Why?
| | Complementary Therapies | 1 | 2007 | 74 | 0.070 |
Why?
| | Gestational Age | 2 | 2021 | 762 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 496 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3470 | 0.060 |
Why?
| | Antioxidants | 1 | 2009 | 527 | 0.060 |
Why?
| | Adult | 2 | 2016 | 30245 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2009 | 814 | 0.060 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2022 | 27 | 0.050 |
Why?
| | Prevalence | 2 | 2021 | 2244 | 0.050 |
Why?
| | Weibel-Palade Bodies | 1 | 2022 | 3 | 0.050 |
Why?
| | Child Day Care Centers | 1 | 2022 | 33 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 41 | 0.050 |
Why?
| | Tomography | 1 | 2021 | 20 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 4593 | 0.050 |
Why?
| | Electric Impedance | 1 | 2021 | 96 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 199 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 185 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2022 | 528 | 0.040 |
Why?
| | Mice | 1 | 2015 | 14679 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 737 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 6189 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 366 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1356 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 174 | 0.030 |
Why?
| | Societies | 1 | 2016 | 36 | 0.030 |
Why?
| | Respiration | 1 | 2016 | 168 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2016 | 115 | 0.030 |
Why?
| | Indiana | 1 | 2015 | 27 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1024 | 0.030 |
Why?
| | Fundoplication | 1 | 2015 | 50 | 0.030 |
Why?
| | Clinical Competence | 1 | 2021 | 882 | 0.030 |
Why?
| | Gastrostomy | 1 | 2015 | 89 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 124 | 0.030 |
Why?
| | Schools, Medical | 1 | 2015 | 121 | 0.030 |
Why?
| | Software | 1 | 2017 | 525 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 633 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 670 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 632 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1157 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 554 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2754 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1832 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 87 | 0.020 |
Why?
| | Air | 1 | 2009 | 32 | 0.020 |
Why?
| | Cell Shape | 1 | 2009 | 53 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 85 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2269 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 181 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2310 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2530 | 0.020 |
Why?
| | Signal Transduction | 1 | 2009 | 4439 | 0.010 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|